Search Results - "Arizon, J"

Malignancy After Heart Transplantation: Incidence, Prognosis and Risk Factors by Crespo‐Leiro, M. G., Alonso‐Pulpón, L., Vázquez de Prada, J. A., Almenar, L., Arizón, J. M., Brossa, V., Delgado, J. F., Fernandez‐Yañez, J., Manito, N., Rábago, G., Lage, E., Roig, E., Diaz‐Molina, B., Pascual, D., Muñiz, J.

“…The Spanish Post‐Heart‐Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003)…”
Get full text

Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History by Delgado, J. F., Alonso‐Pulpón, L., Mirabet, S., Almenar, L., Villa, F. P., González‐Vílchez, F., Palomo, J., Blasco, T., Dolores García‐Cosio, M., González‐Costello, J., Fuente, L., Rábago, G., Lage, E., Pascual, D., Molina, B. D., Arizón, J. M., Muñiz, J., Crespo‐Leiro, M. G.

“…Neoplasm history increases morbidity and mortality after solid organ transplantation and has disqualified patients from transplantation. Studies are needed to…”
Get full text

Incidence and Risk Factors for Nonmelanoma Skin Cancer After Heart Transplantation by Molina, B.D, Leiro, M.G.C, Pulpón, L.A, Mirabet, S, Yañez, J.F, Bonet, L.A, Vilchez, F.G, Delgado, J.F, Manito, N, Rábago, G, Arizón, J.M, Romero, N, Roig, E, Blasco, T, Pascual, D, de la Fuente, L, Muñiz, J

“…Abstract Introduction The incidence of skin cancer in heart transplant (HT) patients is higher than in the general population, reversing the proportion of…”
Get full text

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization? by Gonzalez-Vilchez, F, Vazquez de Prada, J.A, Paniagua, M.J, Gomez-Bueno, M, Arizon, J.M, Almenar, L, Roig, E, Delgado, J, Lambert, J.L, Perez-Villa, F, Sanz-Julve, M.L, Crespo-Leiro, M, Segovia, J, Lopez-Granados, A, Martinez-Dolz, L, Mirabet, S, Escribano, P, Diaz-Molina, B, Farrero, M, Blasco, T

“…Abstract Background In the last decade, mTOR inhibitors (mTOR-is) have become the cornerstone of the calcineurin inhibitor (CNI)-reduced/free regimens aimed to…”
Get full text

Prediction of wheel wear in urban railway transport: comparison of existing models by De Arizon, J., Verlinden, O., Dehombreux, P.

“…One of the most important maintenance costs in tramway transport comes from wear of wheel profiles. In the highly competitive railway market, the prediction of…”
Get full text

Chronic Renal Dysfunction in Maintenance Heart Transplant Patients: The ICEBERG Study by González-Vílchez, F, Arizón, J.M, Segovia, J, Almenar, L, Crespo-Leiro, M.G, Palomo, J, Delgado, J.F, Mirabet, S, Rábago, G, Pérez-Villa, F, Díaz, B, Sanz, M.L, Pascual, D, de la Fuente, L, Guinea, G

“…Abstract Chronic renal dysfunction (CRD) is a major complication after heart transplantation. We sought to describe the renal function over time, to assess the…”
Get full text

Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study by Delgado, J.F., Manito, N., Almenar, L., Crespo-Leiro, M., Roig, E., Segovia, J., Vázquez de Prada, J.A., Lage, E., Palomo, J., Campreciós, M., Arizón, J.M., Rodríguez-Lambert, J.L., Blasco, T., de la Fuente, L., Pascual, D., Rábago, G.

“…J.F. Delgado, N. Manito, L. Almenar, M. Crespo‐Leiro, E. Roig, J. Segovia, J.A. Vázquez de Prada, E. Lage, J. Palomo, M. Campreciós, J.M. Arizón, J.L…”
Get full text

14–Base pair polymorphism of human leukocyte antigen–G as genetic determinant in heart transplantation and cyclosporine therapy monitoring by Torres, M.I, Luque, J, Lorite, P, Isla-Tejera, B, Palomeque, T, Aumente, M.D, Arizon, J, Peña, J

“…Abstract The 14–base pair (bp) polymorphism within the HLA-G gene has been investigated in heart transplant patients for the first time. The 14-bp polymorphism…”
Get full text

Steroid Use in Heart Transplant Patients in Spain in the Current Era: A Multicenter Survey by Crespo-Leiro, M, Delgado, J, Almenar, L, Arizón, J.M, Blasco, T, Brossa, V, De la Fuente, L, Díaz, B, Fernández-Yañez, J, Garrido, I.P, Gómez Bueno, M, González Vílchez, F, Lage, E, López López, L, Mirabet, S, Pérez-Villa, F, Pulpón, L.A, Roig, E, Vázquez de Prada, J.A

“…Abstract Objective Steroid withdrawal (SW) from maintenance therapy in heart transplant patients is still a controversial subject. We designed a questionnaire…”
Get full text

244 Risk Factors for Pericardial and Pleural Effusions in Heart Transplant Recipients Exposed to Everolimus, Azathioprine, or MMF by Zuckermann, A, Arizon, J, Eisen, H, Kobashigawa, J, Lehmkuhl, H, Pellegrini, C, Ross, H, Karpov, A, Barten, M.J

Get full text

332: The Slope of Renal Function in De Novo HTxR. Can We Improve? by Kobashigawa, J, Arizon, J, Dong, G, Eisen, H.J, Junge, G, Schwende, H, Zuckermann, A, Lehmkuhl, H.B

Get full text

245 Wound Healing Events and Effusions with Everolimus Versus MMF Based Regimens in De Novo Heart Transplant Recipients by Zuckermann, A, Eisen, H, Kobashigawa, J, Ross, H, Wang, S, Lehmkuhl, H, Rinaldi, M, Torre, G, Yonan, N, Arizon, J, Pellegrini, C, Lopez, P, Dong, G, Panis, C, Hirt, S

Get full text

Influence of Steroid Dosage, Withdrawal, and Reinstatement on Survival After Heart Transplantation: Results From the RESTCO Study by Delgado Jiménez, J, Almenar Bonet, L, Paniagua Martín, M.J, Gómez Bueno, M, Yáñez, J.F, Arizón del Prado, J.M, Blasco Peiró, T, de la Fuente Galán, L, Garrido Bravo, I.P, Crespo-Leiro, M.G

“…Abstract Background Little information is available regarding the consequences of steroid withdrawal following heart transplantation (HT) in Spain. Methods We…”
Get full text

Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial by Grimm, M., Rinaldi, M., Yonan, N. A., Arpesella, G., Arizón Del Prado, J. M., Pulpón, L. A., Villemot, J. P., Frigerio, M., Rodriguez Lambert, J. L., Crespo‐Leiro, M. G., Almenar, L., Duveau, D., Ordonez‐Fernandez, A., Gandjbakhch, J., Maccherini, M., Laufer, G.

“…We compared efficacy and safety of tacrolimus (Tac)‐based vs. cyclosporine (CyA) microemulsion‐based immunosuppression in combination with azathioprine (Aza)…”
Get full text

Relationship Between Pharmacokinetic Parameters of Cyclosporin and the Incidence of Acute Rejection After Heart Transplantation by Aumente, M.D., Arizón, J.M., Segura, J., López, A., Albornoz, R., Cárdenas, M., Segura, C.

“…Despite two decades of use, there are limited data on the best way to monitor Cyclosporine (CsA) for heart transplantation. The aim of our study was to…”
Get full text

695: Rapid Achievement of Therapeutic Levels and Exposure-Efficacy Analysis in De Novo Cardiac Transplant Recipients on Everolimus-Based Immunosuppression by Livi, U, Arizon, J, Mattei, M.-F, Musumeci, F, Maccherini, M, Almenar, L, Delgado, J, Kleinloog, R, Li, Y, Lehmkuhl, H, Fiocchi, R

Get full text

299: Comparability of Pattern of Occurrence of Pericardial Effusions between Everolimus- and MMF-Based Regimen in De Novo Cardiac Transplant Recipients by Lehmkuhl, H, Ross, H, Arizon, J, Wang, S.-S, Livi, U, Dengler, T, Pellegrini, C, Zuckermann, A, Dong, G, Korom, S, Bara, C

Get full text

161: Impact of De Novo Everolimus-Based Immunosuppression on Wound Healing and Tissue Regeneration in Heart Transplantation by Zuckermann, A, Arizon, J, Wang, S.-S, MacCherini, M, Vermes, E, Bara, C, Ross, H, Laufer, G, Lehmkuhl, H, Keogh, A.M, Sips, C

Get full text

15: Results of a 12-Month, Multicenter, Randomized Trial of Everolimus with Reduced-Exposure Cyclosporine Versus MMF and Standard-Exposure Cyclosporine in De Novo Cardiac Transplant Recipients by Lehmkuhl, H, Livi, U, Arizon, J, Viganò, M, Magelli, C, Boissonnat, P, Gerosa, G, Musumeci, F, Gandjbakhch, I, Vanhaecke, J, Hexham, J.M, Mange, K.C

Get full text

Health-related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross-sectional study by Delgado, J.F., Almenar, L., González-Vilchez, F., Arizón, J.M., Gómez, M., Fuente, L., Brossa, V., Fernández, J., Díaz, B., Pascual, D., Lage, E., Sanz, M., Manito, N., Crespo-Leiro, M.G.

“…A multicenter cross‐sectional study was conducted to determine the current heart transplant (HTx) outcomes in Spain. Clinical and functional status,…”
Get full text